Regulation of MDA-MB-231 cell proliferation by GSK-3β involves epigenetic modifications under high glucose conditions

Experimental Cell Research

Volumn 324, Issue 1, 2014, Pages 75-83

  Gupta, Chanchal ^a   Kaur, Jasmine ^a   Tikoo, Kulbhushan ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Breast cancer; DNA methylation; GSK 3 ; Histone H3 phosphorylation; Hyperglycemia

Indexed keywords

CYCLIN D1; DNA; DNA METHYLTRANSFERASE 1; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE H3; MATRILYSIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; ENZYME ACTIVATION; EPIGENETICS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOPRECIPITATION; MDA MB 231 CELL; METASTASIS; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

GASTROPODA;

BREAST CANCER; DNA METHYLATION; GSK-3Β; HISTONE H3 PHOSPHORYLATION; HYPERGLYCEMIA;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HISTONES; HUMANS; HYPERGLYCEMIA; PROTAMINE KINASE;

EID: 84899485973     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.03.019     Document Type: Article

References (60)

1. Abiola M., Favier M., Christodoulou-Vafeiadou E., Pichard A.L., Martelly I., Guillet-Deniau I. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One 2009, 4:e8509.
2. Barres R., Zierath J.R. DNA methylation in metabolic disorders. Am. J. Clin. Nutr. 2011, 93:897S-900S.
3. Bordonaro M. Role of Wnt signaling in the development of type 2 diabetes. Vitam. Horm. 2009, 80:563-581.
4. Bostrom P., Soderstrom M., Vahlberg T., Soderstrom K.O., Roberts P.J., Carpen O., Hirsimaki P. MMP-1 expression has an independent prognostic value in breast cancer. BMC Cancer 2011, 11:348.
5. Cao Q., Lu X., Feng Y.J. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res. 2006, 16:671-677.
6. Caspi M., Zilberberg A., Eldar-Finkelman H., Rosin-Arbesfeld R. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner. Oncogene 2008, 27:3546-3555.
7. Chen Y., Wang K., Qian C.N., Leach R. DNA methylation is associated with transcription of Snail and Slug genes. Biochem. Biophys. Res. Commun. 2013, 430:1083-1090.
8. Choi H.S., Choi B.Y., Cho Y.Y., Mizuno H., Kang B.S., Bode A.M., Dong Z. Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation. Cancer Res. 2005, 65:5818-5827.
9. Choi S.W., Friso S. Epigenetics: a new bridge between nutrition and health. Adv. Nutr. 2010, 1:8-16.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
11. Ciaraldi T.P., Carter L., Mudaliar S., Henry R.R. GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle. Mol. Cell Endocrinol. 2010, 315:153-158.
12. De Craene B., Berx G. Snail in the frame of malignant tumor recurrence. Breast Cancer Res. 2006, 8:105.
13. Dong Z., Bode A.M. The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation. Mol. Carcinog. 2006, 45:416-421.
14. Embi N., Rylatt D.B., Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 1980, 107:519-527.
15. Erdal E., Ozturk N., Cagatay T., Eksioglu-Demiralp E., Ozturk M. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. Int. J. Cancer 2005, 115:903-910.
16. Etoh T., Kanai Y., Ushijima S., Nakagawa T., Nakanishi Y., Sasako M., Kitano S., Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 2004, 164:689-699.
17. Fischle W. Talk is cheap-cross-talk in establishment, maintenance, and readout of chromatin modifications. Genes Dev. 2008, 22:3375-3382.
18. Fuso A. The 'golden age' of DNA methylation in neurodegenerative diseases. Clin. Chem. Lab. Med. 2012, 1-12.
19. Gezgen G., Roach E.C., Kizilarslanoglu M.C., Petekkaya I., Altundag K. Metabolic syndrome and breast cancer: an overview. J. BUON 2012, 17:223-229.
20. Gupta C., Tikoo K. High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells. J. Mol. Endocrinol. 2013, 51:119-129.
21. Hans F., Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001, 20:3021-3027.
22. Henriksen E.J. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes. Curr. Diabetes Rev. 2010, 6:285-293.
23. Huang T.H., Perry M.R., Laux D.E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 1999, 8:459-470.
24. Ip W., Chiang Y.T., Jin T. The involvement of the Wnt signaling pathway and TCF7L2 in diabetes mellitus: the current understanding, dispute, and perspective. Cell. Biosci. 2012, 2:28.
25. Jacobs K.M., Bhave S.R., Ferraro D.J., Jaboin J.J., Hallahan D.E., Thotala D. GSK-3beta: a bifunctional role in cell death pathways. Int. J. Cell Biol. 2012, 2012:930710.
26. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: Cancer J. Clin. 2011, 61:69-90.
27. Jin T., Liu L. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol. Endocrinol. 2008, 22:2383-2392.
28. Jones P.A. DNA methylation errors and cancer. Cancer Res. 1996, 56:2463-2467.
29. Kim M., Long T.I., Arakawa K., Wang R., Yu M.C., Laird P.W. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 2010, 5:e9692.
30. Kokkinos M.I., Wafai R., Wong M.K., Newgreen D.F., Thompson E.W., Waltham M. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. Cells Tissues Organs 2007, 185:191-203.
31. Kondo Y. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med. J. 2009, 50:455-463.
32. Kulikov R., Boehme K.A., Blattner C. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. Mol. Cell Biol. 2005, 25:7170-7180.
33. Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett. 2009, 273:194-200.
34. Mendez M.G., Kojima S., Goldman R.D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010, 24:1838-1851.
35. Monier K., Mouradian S., Sullivan K.F. DNA methylation promotes Aurora-B-driven phosphorylation of histone H3 in chromosomal subdomains. J. Cell Sci. 2007, 120:101-114.
36. Nikoulina S.E., Ciaraldi T.P., Mudaliar S., Carter L., Johnson K., Henry R.R. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 2002, 51:2190-2198.
37. Ougolkov A.V., Fernandez-Zapico M.E., Savoy D.N., Urrutia R.A., Billadeau D.D. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 2005, 65:2076-2081.
38. Pasco M.Y., Catoire H., Parker J.A., Brais B., Rouleau G.A., Neri C. Cross-talk between canonical Wnt signaling and the sirtuin-FoxO longevity pathway to protect against muscular pathology induced by mutant PABPN1 expression in C. elegans. Neurobiol. Dis. 2010, 38:425-433.
39. Peng D.F., Kanai Y., Sawada M., Ushijima S., Hiraoka N., Kitazawa S., Hirohashi S. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis 2006, 27:1160-1168.
40. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6:597-610.
41. Schisano B., Tripathi G., McGee K., McTernan P.G., Ceriello A. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia 2011, 54:1219-1226.
42. Shakoori A., Ougolkov A., Yu Z.W., Zhang B., Modarressi M.H., Billadeau D.D., Mai M., Takahashi Y., Minamoto T. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem. Biophys. Res. Commun. 2005, 334:1365-1373.
43. Sproul D., Meehan R.R. Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief. Funct. Genomics 2013.
44. Sun T., Aceto N., Meerbrey K.L., Kessler J.D., Zhou C., Migliaccio I., Nguyen D.X., Pavlova N.N., Botero M., Huang J., Bernardi R.J., Schmitt E., Hu G., Li M.Z., Dephoure N., Gygi S.P., Rao M., Creighton C.J., Hilsenbeck S.G., Shaw C.A., Muzny D., Gibbs R.A., Wheeler D.A., Osborne C.K., Schiff R., Bentires-Alj M., Elledge S.J., Westbrook T.F. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 2011, 144:703-718.
45. Szyf M. The role of DNA methyltransferase 1 in growth control. Front. Biosci. 2001, 6:D599-D609.
46. Szyf M., Pakneshan P., Rabbani S.A. DNA methylation and breast cancer. Biochem. Pharmacol. 2004, 68:1187-1197.
47. Tikoo K., Tripathi D.N., Kabra D.G., Sharma V., Gaikwad A.B. Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Lett. 2007, 581:1071-1078.
48. Ulirsch J., Fan C., Knafl G., Wu M.J., Coleman B., Perou C.M., Swift-Scanlan T. Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Res. Treat. 2013, 137:383-396.
49. Ullmann U., Gilles C., De Rycke M., Van de Velde H., Sermon K., Liebaers I. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol. Hum. Reprod. 2008, 14:169-179.
50. Villarreal-Garza C., Shaw-Dulin R., Lara-Medina F., Bacon L., Rivera D., Urzua L., Aguila C., Ramirez-Morales R., Santamaria J., Bargallo E., Mohar A., Herrera L.A. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Exp. Diabetes Res. 2012, 2012:732027.
51. G. Wishart, Breast Cancer Statistics, 2012, Available at: (accessed 25 April 2013). http://www.gordonwishart.com/news/breast-cancer-statistics-2012/.
52. Wolf I., Sadetzki S., Catane R., Karasik A., Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 2005, 6:103-111.
53. Wu A.H., Yu M.C., Tseng C.C., Stanczyk F.Z., Pike M.C. Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 2007, 28:1561-1566.
54. Wu D., Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci. 2010, 35:161-168.
55. Yang X., Yan L., Davidson N.E. DNA methylation in breast cancer. Endocr. Relat. Cancer 2001, 8:115-127.
56. Yen R.W., Vertino P.M., Nelkin B.D., Yu J.J., el-Deiry W., Cumaraswamy A., Lennon G.G., Trask B.J., Celano P., Baylin S.B. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res. 1992, 20:2287-2291.
57. Yu X.Y., Geng Y.J., Liang J.L., Zhang S., Lei H.P., Zhong S.L., Lin Q.X., Shan Z.X., Lin S.G., Li Y. High levels of glucose induce "metabolic memory" in cardiomyocyte via epigenetic histone H3 lysine 9 methylation. Mol. Biol. Rep. 2012, 39:8891-8898.
58. Zhang Y., Chen F.Q., Sun Y.H., Zhou S.Y., Li T.Y., Chen R. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. J. Exp. Clin. Cancer Res. 2011, 30:98.
59. Barlev N.A., Liu L., Chehab N.H., Mansfield K., Harris K.G., Halazonetis T.D., Berger S.L. Acetylation of p53 Activates Transcription through Recruitment of Coactivators/Histone Acetyltransferases. Mol. Cell 2001, 8:1243-1254.
60. Vrba L., Junk D.J., Novak P., Futscher B.W. p53 induces distinct epigenetic states at its direct target promoters. BMC Genomics 2008, 9:486.